Back
Day Range
$13.62
$13.63
52-Week Range
$6.47
$13.68
Volume
449,921
50D / 200D Avg
$11.93
/
$9.24
Prev Close
$13.62
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -150.2 | 0.4 |
| P/B | 1.3 | 2.9 |
| ROE % | -0.9 | 3.8 |
| Net Margin % | -0.4 | 3.9 |
| Rev Growth 5Y % | -1.1 | 10.0 |
| D/E | 0.9 | 0.2 |
Key Takeaways
Revenue declined -1.07% annually over 5 years
Generating 65.80M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.51%
Capital efficient — spends only 0.46% of revenue on capex
ROIC of 4.63% — low return on invested capital
Interest coverage of 1.88× — tight debt servicing
Growth
Revenue Growth (5Y)
-1.07%
Revenue (1Y)2.44%
Earnings (1Y)N/A
FCF Growth (3Y)21.06%
Quality
Return on Equity
-0.87%
ROIC4.63%
Net Margin-0.43%
Op. Margin6.02%
Safety
Debt / Equity
0.94
Current Ratio1.63
Interest Coverage1.88
Valuation
P/E Ratio
-150.18
P/B Ratio1.29
EV/EBITDA17.98
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.44% | Revenue Growth (3Y) | 0.65% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -1.07% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.06B | Net Income (TTM) | -4.60M |
| ROE | -0.87% | ROA | -0.39% |
| Gross Margin | 46.92% | Operating Margin | 6.02% |
| Net Margin | -0.43% | Free Cash Flow (TTM) | 65.80M |
| ROIC | 4.63% | FCF Growth (3Y) | 21.06% |
| Safety | |||
| Debt / Equity | 0.94 | Current Ratio | 1.63 |
| Interest Coverage | 1.88 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -150.18 | P/B Ratio | 1.29 |
| P/S Ratio | 0.65 | PEG Ratio | 1.05 |
| EV/EBITDA | 17.98 | Dividend Yield | 0.00% |
| Market Cap | 690.85M | Enterprise Value | 1.15B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.06B | 1.03B | 1.05B | 1.07B | 1.11B |
| Net Income | -4.60M | -156.20M | -80.50M | -40.40M | 111.10M |
| EPS (Diluted) | -0.09 | -3.11 | -1.61 | 1.25 | 28.49 |
| Gross Profit | 497.30M | 504.00M | 510.70M | 545.50M | 592.70M |
| Operating Income | 63.80M | -115.10M | -47.60M | -11.40M | 142.90M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.17B | 1.23B | 1.43B | 1.53B | 1.72B |
| Total Liabilities | 603.00M | 672.10M | 731.90M | 751.50M | 236.70M |
| Shareholders' Equity | 534.00M | 523.50M | 669.70M | 741.70M | 1.47B |
| Total Debt | 500.00M | 569.50M | 610.10M | 625.20M | 56.90M |
| Cash & Equivalents | 43.60M | 28.40M | 27.40M | 22.90M | 5.40M |
| Current Assets | 205.60M | 192.70M | 210.10M | 211.80M | 178.80M |
| Current Liabilities | 126.30M | 126.20M | 137.70M | 132.90M | 136.50M |